pillbase.ru

ERIVEDGE

Active substance: vismodegib

CAPSULE · VISMODEGIB 150 mg/1

United StatesActive

Marketing holder: Genentech, Inc.

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
EU 1
  • Erivedge
    vismodegib
    EMEA/H/C/002602
    Roche Registration GmbH
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1209d-6d9f-7dc4-96d8-09fff423cefc;count=1 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
50242-140
Registration status
Active
Dispensing
Prescription only
Route
ORAL
Sources
  • product · openFDA NDC · 50242-140 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 50242-140 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 50242-140 · Verified 2026-10-09 · open in source